# Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery

> **NCT00578214** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 75 (actual)

## Conditions studied

- Basal Cell Carcinoma
- Squamous Cell Carcinoma
- Skin Cancer
- Anxiety

## Interventions

- **DRUG:** Randomized Midazolam
- **OTHER:** Placebo
- **DRUG:** Local Anesthesia
- **DRUG:** Prospective Midazolam

## Key facts

- **NCT ID:** NCT00578214
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-04
- **Final completion:** 2008-06
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2012-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00578214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00578214, "Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00578214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*